NASDAQ Archives - Page 2 of 6

Camtek Ltd. has Set Ex-Dividend for November 21, 2017

Starting November 21, 2017, Camtek Ltd. (NASDAQ:$CAMT) will begin trading ex-dividend, with a cash dividend payment of $0.28 per share scheduled to be paid on November 30, 2017. Those shareholders who purchased Camtek stock before ... [Read]

A Look at Anavex Life Sciences Corp.’s Current Standings

Nov 14 Jen Jiang

Anavex Life Sciences Corp. (NASDAQ:$AVXL) is a clinical-stage biopharmaceutical company engaged in the development of drug candidates. The company’s lead compounds include ANAVEX 2-73, ANAVEX PLUS, a combination of ANAVEX2-73 with donepezil, ANAVEX 19-144, ANAVEX ... [Read]

Axcelis Technologies Continues Strong Growth Post 3Q17 Report Release

Nov 14 Jen Jiang

Axcelis Technologies (NASDAQ:$ACLS) shares climbed 20.3% in October. The big gains appear to correspond with news of the semiconductor equipment company’s addition to the S&P SmallCap 600. On October 11th, the company announced that it ... [Read]

Impax Laboratories Inc. Plunges 5.74% During Monday Trading

Nov 14 Jen Jiang

As of Monday trading on November 13th, Impax Laboratories Inc. (NASDAQ:$IPXL) plunged a cool 5.74%, or a loss of $-1.05 per share, to close at $17.25. Impax Laboratories is a pharmaceutical company, developing and commercializing ... [Read]

A Closer Look at Iovance Biotherapeutics Inc.’s Recent Trading Lows

Nov 14 Jen Jiang

Iovance Biotherapeutics Inc. (NASDAQ:$IOVA) recently had a low trading volume day. The volume for the company on November 13th was recorded to 0.39 million contracts. Over the past three months, the average daily trading volume ... [Read]

Why You Shouldn’t be Fooled By SunPower Corp.’s Ostensibly Promising Q3 Results

Nov 6 Jen Jiang

Despite SunPower Corp. (NASDAQ:$SPWR) beating consensus, investors remain skeptical on the company’s profitability. Specifically, SunPower posted strong Q3 results due to earlier-than-expected completion of several projects. When it comes to project companies, however, this type ... [Read]

Xcerra Corp. VP Sells 50,000 Shares, Amidst Stagnant Shares

Nov 6 Jen Jiang

Xcerra Corp. (NASDAQ:$XCRA) have been trending negatively for the past week. Let’s take a look at the numbers. The company itself is a provider of test and handling capital equipment, interface products, test fixtures, and ... [Read]

Anavex Life Sciences Corp. Releases New Clinical Data of Investigational Alzheimer’s Drug

Nov 6 Jen Jiang

Anavex Life Sciences Corp. (NASDAQ:$AVXL) is a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, including Alzheimer’s disease, other central nervous systems (CNS) diseases, pain and various types of ... [Read]

Current Wall Street Outlooks on Impax Laboratories, Inc.

Oct 30 Jen Jiang

Following the Food and Drug Administration’s approval of its latest generic Renvela drug last week, Impax Laboratories, Inc. (NASDAQ:$IPXL) shares rose 5.7% to $21.50. The company indicated that sales of the sevelamer carbonate, the generic ... [Read]

What to Expect From Rent-A-Center, Inc.’s 3Q17 Earnings Report

Oct 25 Jen Jiang

Rent-A-Center, Inc. (NASDAQ:$RCII) is scheduled to release 3Q17 results on Oct 30th. What should you expect? Can the rent-to-own store operator post live up to expectations? Let’s take a look. Analysts speculate Rent-A-Center shares to ... [Read]